Dragonfly raises financing round

Dragonfly Therapeutics Inc. (Cambridge, Mass.) raised an undisclosed amount in a financing round from the Celgene Switzerland LLC affiliate of Celgene Corp. (NASDAQ:CELG), Disney family members, the Duke of Bedford and other family offices.

The company is developing trispecific antibodies that direct endogenous NK cells toward tumor cells (see BioCentury, March 3)...